A detailed history of Pnc Financial Services Group, Inc. transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 1,520 shares of CRDF stock, worth $6,596. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,520
Previous 1,520 -0.0%
Holding current value
$6,596
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$1.45 - $2.09 $754 - $1,086
520 Added 52.0%
1,520 $2,000
Q4 2022

Feb 10, 2023

BUY
$1.22 - $1.66 $1,220 - $1,660
1,000 New
1,000 $1,000
Q1 2022

May 12, 2022

SELL
$2.11 - $7.25 $6,330 - $21,750
-3,000 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$5.18 - $7.24 $15,540 - $21,720
3,000 New
3,000 $18,000

Others Institutions Holding CRDF

About Cardiff Oncology, Inc.


  • Ticker CRDF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,334,900
  • Market Cap $188M
  • Description
  • Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...
More about CRDF
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.